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Abstract 
Background: Co-infection is the simultaneous infection of host by multiple 
pathogenic species, which may co-exist together or not 
Objective: To investigate the prevalence and co-infection of malaria, hepatitis B 
and HIV/AIDS using four different locations in Akure, Ondo State.  
Methods: Blood samples were aseptically collected from the left thumbs of 500 
patients visiting health centres in Akure using sterile lancets. Thin and thick smear 
of the blood samples were observed for malaria parasites using X100 magnification 
of the light microscope. Hepatitis B and HIV/AIDS were tested using diagnostic test 
kits.  
Results: The results show that highest prevalence of malaria was observed in Oba-
Ile (82.09%) while the lowest was observed in Ala-Ajagbusi (73.17%). Similarly, 
highest age prevalence of malaria was observed in age group 11-20 years (90.8%) 
while the lowest prevalence was found in age group 21-30 years (70.03%). Highest 
prevalence of hepatitis (7.06%) was observed in Orita-Obele while the lowest 
prevalence was observed in Ala- Ajagbusi (4.88%).  HIV/AIDS infection was found 
Orita-Obele (1.76%, n=3) and Ala-Ajagbusi (2.44%, n=2). The results show that all 
the individuals that tested positive to hepatitis B virus and HIV also tested positive 
to malaria. Also, 3 of the 5 individuals infected with HIV/AIDS tested positive to 
hepatitis B virus.  Similarly, malaria, hepatitis B virus and HIV co-exist in 2 
individuals; 1 in age group 21-30 years and 1 in age group 31-40 years.  
Conclusion: Coinfection of malaria with hepatitis and HIV/AIDS suggests that 
malaria can co-exist in the same host. This calls for prompt malaria treatment among 
the immunocompromised patients. More so, there should be adequate and consistent 
public health advocacy programs, to enlighten the population about malaria, 
hepatitis B and HIV/AIDS in order to completely mitigate the disease spread in the 
area. 
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INTRODUCTION 
 Co-infection is the simultaneous infection of a host 
by multiple pathogenic species; which may co-exist 
together or not. Most co-infections are transmitted 
through body fluids (saliva, blood, sweat etc). Malaria 
is a mosquito-borne infectious disease caused by 
protozoan parasites of blood-Plasmodium species; 
affecting humans and other animals.  
 
* Corresponding author: 
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 The disease is most commonly transmitted by an 
infected female Anopheles mosquito. The mosquito 
bite introduces the parasites from the mosquito's saliva 
into a person's blood. The parasites travel to the liver 
where they mature and reproduce. Malaria causes 
symptoms that typically include fever, tiredness, 
vomiting, and headaches1. In severe cases it can cause 
yellow skin, seizures, coma or death. Symptoms 
usually begin ten to fifteen days after being bitten. If 
not properly treated, people may have recurrences of 
the disease months later2. Prevalence of malaria in 
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Akure has previously been reported in the study area to 
be 45.79%3. The risk of malaria can be reduced by 
preventing mosquito bites through the use of mosquito 
nets and insect repellents, or with mosquito control 
measures such as spraying insecticides and habitat 
evacuation4. Hepatitis B is an infectious disease caused 
by the hepatitis B virus (HBV) that affects the liver. It 
can cause both acute and chronic infections5. Hepatitis 
B virus is transmitted through exposure to infectious 
blood or body fluids. It is 50 to 100 times more 
infectious than HIV. Possible forms of transmission 
include sexual contact, blood transfusions and 
transfusion with other human blood products, re-use of 
contaminated needles and syringes, and vertical 
transmission from mother to child (MTCT) during 
childbirth. Without intervention, a mother who is 
positive for HBsAg has a 20% risk of passing the 
infection to her progeny at birth6. Many people have no 
symptoms during the initial infection while some 
develop a rapid onset of sickness with vomiting, 
yellowish skin, tiredness, dark urine and abdominal 
pain1. Chronic symptoms of infection include cirrhosis 
and liver cancer5.7. Often, these symptoms last a few 
weeks and rarely does the initial infection result in 
death. It may take 30 to 180 days for symptoms to 
begin. In those who get infected around the time of 
birth 90% develop chronic hepatitis B while less than 
10% of those infected after the age of five get the 
vaccine against HBV1. 
 The human immunodeficiency virus (HIV) is a 
lentivirus (a subgroup of retrovirus) that causes HIV 
infection and over time acquired immunodeficiency 
syndrome (AIDS). AIDS is a condition in humans in 
which progressive failure of the immune system allows 
life-threatening opportunistic infections8. Infection 
with HIV occurs by the transfer of blood, pre-ejaculate 
semen, vaginal fluids or breast milk. Within these 
bodily fluids, HIV is present as both free virus particles 
and virus within infected immune cells9. HIV infects 
vital cells in the human immune system such as helper 
T cells (specifically CD4+ T cells), macrophages, and 
dendritic cells. HIV infection leads to low levels of 
CD4+ T cells through a number of mechanisms, 
including pyroptosis of abortively infected T cells, 
apoptosis of uninfected bystander cells, direct viral 
killing of infected cells, and killing of infected CD4+ T 
cells by CD8 cytotoxic lymphocytes that recognize 
infected cells10. When CD4+ T cell numbers decline 
below a critical level, cell-mediated immunity is lost, 
and the body becomes progressively more susceptible 
to opportunistic infections like malaria, tuberculosis, 
hepatitis B and so on11. This research seeks to 
determine the prevalence of malaria, hepatitis B, 
HIV/AIDS and their co-infection in Akure metropolis; 
Ondo State. 
 
MATERIALS AND METHODS  
 Prior to the commencement of the research, 
approvals for the study were obtained from the 
Department of Disease Control of the Ondo State 
Ministry of Health. Also, informed consent of the 
subjects was obtained after focus group discussion in 
English and native Language, where the participants 
were made to know the benefits and discomfort of their 
participation in the study. Four community health 
centres within Akure metropolis were considered as 
sample collection centres. These include: Health 
centres in FUTA where the subjects comprised of 
students and lecturers, Orita-Obele where the subjects 
comprised of civil servants, traders and students, Ala-
Ajagbusi which comprised of civil servant and traders, 
Oba-Ile which comprised of public servants, retirees 
and traders. Five hundred symptomatic patients who 
came to the community health centres for medical 
check-up were randomly selected for the study. 
Subsequently, blood samples were aseptically 
collected from the left thumb of the subjects using a 
sterile lancet. Before collection, the thumb was cleaned 
with cotton wool dampened with 70% ethanol to 
remove dirt and oils from the ball of the finger. Then 
the thumb was stroked to stimulate blood circulation 
and gentle pressure was applied on the finger before it 
was gently punctured by the sterile lancet. Drops of the 
blood were collected in the EDTA bottles for thin and 
thick film preparation and blood testing. Respondent 
fingers were immediately swabbed with cotton wool 
soaked with 70% ethanol to prevent entry of pathogens 
into the wound. Thin and thick smears of the samples 
were prepared on sterile slides and subsequently 
stained with Giemsa at pH 7.2.  The slide preparations 
were observed for Falciparum malaria under X 1000 
magnification of the light microscope. The Alere 
Determine HIV-1/2 Test System (home collection kit) 
also known as Abbot kit (produced by Abbot 
Table 1. Prevalence of Malaria, Hepatitis B and HIV/ AIDS in Akure 
Location Number examined Malaria      Hepatitis B    HIV /AIDS 
    n (%)           n (%)         n (%) 
 FUTA  181 140 (77.35)       11 (6.08) 0 ( 0.00) 
 Orita Obele  170 130 (76.47)       12 (7.06)     3 (1.76) 
   Ala-Ajagbusi 82  60 (73.17)         4 (4.88) 2 (2.44) 
   Oba-Ile 67  55 (82.09)     4 (5.97) 0 (0.00) 
  Total 500 385 (77.00)   31 (6.02) 5 (1.00) 
 
Gender     
  Male 167 126 (75.45) 11 (6.59) 2 (1.19) 
 Female 333 259 (77.78) 20 (6.01) 3 (0.90) 
 Total 500 385 (77.00) 31 (6.02) 5 (1.00) 
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Diagnostics) was used to diagnose HIV/AIDS infection 
while the HBsAg rapid test strips were used for 
Hepatitis B test among the subjects. Data obtained 
were subjected to Chi-square (χ2) and one-way 
ANOVA (Analysis of Variance) at p<0.05 using SPSS 
21.0 (Statistical Package for the Social Sciences).  
 
RESULTS 
 Total of 500 respondents were sampled during the 
study which consist of 181, 170, 82 and 67 from 
FUTA, Orita-Obele, Ala-Ajagbusi and Oba-Ile 
respectively (Table 1). Different erythrocytic stages 
(trophozoites, schizonts and merozoites) of 
Falciparum malaria parasite were observed in 385 
respondent blood samples given a total prevalence of 
77%. One hundred and forty (140) subjects of the 181 
subjects observed in Federal University of Technology 
Akure (FUTA) were positive to malaria parasite given 
a prevalence of 77.35%, 130 subjects of the 170 
sampled in Orita Obele Estate were infected with 
malaria parasite while 60 and 55 subjects were positive 
with prevalence of 73.17% and 82.09% in Ala-
Ajagbusi and Oba-Ile Estate respectively (Table 1). 
The result further shows that of the 167 males 
examined, 126 of them were infected with malaria 
parasite given a prevalence of 75.45%. Two hundred 
and fifty-nine females (259) of the 333 females were 
also infected with malaria parasite.  
 The result presented in Table 1 also shows that of 
the 181 subjects examined for Hepatitis B in FUTA, 11 
of them were positive given a prevalence of 6.08%. In 
Orita-Obele, 12 subjects of the 170 subjects were 
positive for Hepatitis B given a prevalence of 7.06%. 
Meanwhile, in Ala-Ajagbusi and Oba-Ile, 4 subjects 
each were positive for the disease given prevalence of 
4.88% and 5.97% respectively. Generally, a total of 31 
subjects of the 500 subjects were observed to be 
positive for Hepatitis B virus in the study area, given a 
total prevalence of 6·2%. Among the 500 subjects 
examined for Hepatitis B, 167 were male, while 333 
were female gender. Number of male and female 
infected with Hepatitis B Virus were 11 and 20 given 
prevalence of 6·6% and 6.0 respectively. Chi-Square 
analysis of the data shows that there is no significant 
difference in the prevalence between gender (P>0·05).    
 The HIV/AIDS result as observed in different 
locations in Akure reveals that no subject in FUTA and 
Oba-Ile was infected with HIV/AIDS while 2 and 3 
subjects were infected with the disease in Orita-Obele 
and Ala-Ajagbusi with prevalence of 1.76% and 2.44% 
respectively. A total infection rate of 1.0% was 
observed in the study area. Of the 5 subjects that were 
positive for HIV/AIDS infection, 2 (1·18%) were male 
while 3 (1%) were female subjects. 
 Table 2 shows the distribution of malaria infection 
among the age groups. The highest prevalence of 
malaria (90.8%) was noted in age-group 11-20 years 
while the least prevalence (70·03%) of the disease was 
observed in age-group 21-30 years.  
 The prevalence of HIV/AIDS infection was not 
significantly different between gender (χ2=0·099; 
p=0.753, p>0·05). Coinfection of the malaria parasite 
and hepatitis B virus was observed in 31 subjects in this 
study, 12 subjects were observed to harbor both 
malaria parasite and hepatitis B virus in FUTA, 14 
subjects harbor the two parasites in Orita-Obele, 3 
subjects harbor the two parasites in Ala-Ajagbusi while 
2 subject harbor the two parasites in Oba-Ile (Table 3). 
Similarly, coinfection of malaria and HIV was noted in 
5 subjects; 3 in Orita-Obele and 2 in Ala-Ajagbusi. It 
was generally observed that all the 5 subjects that were 
positive for HIV/AIDS also tested positive for malaria. 
In contrast, of the 5 subjects positive for HIV/AIDS, 
only 3 of them tested positive for hepatitis B virus; 2 
individuals in Orita-Obele and 1 in Ala-Ajagbusi 
(Table 3). 
 Coinfection of diseases as presented in Table 4 
shows that coinfection was absent in age groups 1-10 
and 11-20 years. Meanwhile, coinfection of malaria 
and hepatitis B virus was observed in 12 subjects in age 
group 21-30 years, 14 subjects in age group 31-40 
years, 3 and 2 subjects in 41-50 years and above 51 
years old respectively. One individual each was noted 
to harbor malaria and HIV; hepatitis and HIV in age 
group 21-30 years. Also, 3 individuals harbor malaria 
and HIV in age group 31-40 years, 2 individuals harbor 
hepatitis B and HIV while the three diseases (malaria, 
hepatitis B and AIDS) co-exist in 1 individual each in 
age group 21-30years and 31-40 years.  It was 
generally observed that co-infection of malaria, 
hepatitis B and HIV infection was found only in age 
groups 31-40 and 41-50 years (Table 4). 
 
DISCUSSION 
 This study reveals that of the 500 subjects 
examined for malaria, hepatitis B and HIV/AIDS 
.        Table 2. Distribution of Malaria Infection among Age groups in Akure 
Age group 
(Years) 
Number 
Examined 
Infected  
Individuals (n)  
Prevalence 
(%) 
1 -  10 8 6  75.00 
11-20 87 79  90.80 
21-30 307 215  70.03 
31-40 55 51  82.09 
41-50 25 19  76.00 
51 and above 18 15  83.30 
Total 500 385  77.00 
.         χ2=25·898; p=0.00, p<0·05 
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infections in the study area, 385 were infected with 
malaria given a total prevalence of 77%, 31 subjects 
were infected with hepatitis B virus given a total of 
6.2% and 5 subjects were positive to HIV test given a 
total prevalence of 1.0%.  It was further observed that 
the prevalence of the three diseases was not 
significantly different among the four locations 
observed in the study. The subjects that were positive 
to malaria infection were given antimalarial drugs by 
competent medical personnel in the Health Centers 
while those that were positive for hepatitis and 
HIV/AIDS were referred to Virology department in 
Ondo State Teaching Hospital and HIV/AIDS Centre 
in Akure for further confirmatory tests, counselling and 
therapy. The highest prevalence of malaria (77%) when 
compared to the other two diseases (hepatitis B and 
HIV/AIDS) shows that malaria is the most dominant 
disease in Akure metropolis. This finding is in 
accordance with the World Health Organization 
Malaria report12 that malaria is the most important 
public health problem in terms of morbidity and 
mortality causing more than 200 million morbidity and 
655,000 mortality every year. The high prevalence of 
malaria has been associated with the increase in the 
population living in malaria endemic regions13 . 
 Low infection rates of hepatitis B (6.2%) and 
HIV/AIDS (1.0%) might be as a result of increase in 
the public enlightenment in the area. The people living 
in endemic areas which include Akure metropolis are 
aware of the various preventive measures for the two 
diseases. Low prevalence of hepatitis B recorded in the 
study area is supported by Denue 14 at medical wards 
of University of Maiduguri Teaching Hospital, Nigeria 
where a low prevalence of 12.3% for hepatitis B virus 
was reported among HIV positive patients. The 
distribution of malaria among age groups shows that 
the prevalence of the disease is higher among 11-20 
years and 30-41 years. This shows that the lower age 
groups are more predisposed to malaria infections than 
the older age groups. This might be because the lower 
age groups are still building up immunity against 
malaria parasites compared to the older age groups 
where their immunity has been fully developed to 
combat the malaria parasites. 
 The results of this study further show that there is 
no significant difference in prevalence of malaria, 
hepatitis B and HIV/AIDS between genders. This 
implies that gender has nothing to do with the 
transmission of the diseases. Both gender have equal 
chance of contracting the diseases when exposed to the 
parasites. In addition, it was observed that malaria 
parasite, hepatitis B virus and Human 
Immunodeficiency Virus can co-habit in 
immunodeficient or immunocompromised hosts. All 
the individuals that were positive for hepatitis B and 
HIV/AIDS tests were also positive for malaria test.  
This also suggests that individuals with HIV/AIDS 
have higher risk of contracting hepatitis B virus. It 
shows that malaria and HIV/AIDS could co-exist in 
human host.  This coinfection characteristic of malaria 
parasite and HIV has also been reported by Orlov et 
al15. The result of this study also shows that three of the 
five individuals infected with HIV/AIDS also tested 
positive for hepatitis B virus. This shows that presence 
of HIV in a host increases the prevalence of hepatitis B 
virus in the same host and vice versa. The coinfection 
of HBV and malaria parasite noted in this research is 
contrary to the report of Sharif et al16 in Kano. The 
authors reported that presence of HBV and malaria co-
infection reduces the severity of HBV and malaria as 
Table 3. Coinfection of Malaria, Hepatitis B and HIV/AIDS in Akure 
Location Number 
Examined 
Coinfection of 
Malaria & 
Hepatitis 
Coinfection of 
Malaria & 
HIV 
Coinfection of  
Hepatitis & 
HIV 
Coinfection of 
Malaria, Hepatitis & 
HIV 
FUTA 181 8 (4.42%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Orita Obele 170 9 (5.29%) 3 (1.76%) 2 (1.18%) 1 (0.59%) 
Ala-Ajagbusi 82 2 (2.44%) 2 (2.44%) 1 (1.23%) 1 (1.22%) 
Oba-Ile 67 1 (1.49%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Total 500 20 (4.0%) 5 (1.0%) 3 (0.6%) 2 (0.4%) 
Note: Figures in brackets are prevalence of coinfections 
 
Table 4. Coinfection of Malaria, Hepatitis B and HIV/AIDS Infections among Age groups in Akure 
Age group 
(years) 
 Number 
Examined 
Coinfection of 
Malaria & 
Hepatitis 
Coinfection of 
Malaria & HIV 
Coinfection 
of  Hepatitis 
& HIV 
Coinfection of 
Malaria, 
Hepatitis 
& HIV 
1-10  8 0 0 0 0 
11-20  87 0 0 0 0 
21-30  307 3 1 1 1 
31-40  55 8 3 2 1 
41-50  25 4 1 0 0 
51 above  18 3 0 0 0 
Total  500 20 5 3 2 
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mono infection in Kano. The coinfection of HBV and 
malaria observed in this study suggests that HBV and 
malaria parasite can co-exist in a host and HBV 
patients have the higher risk of contracting malaria. 
This result concurs with the report of Barcus et al17. 
The authors in their study showed that the presence of 
HBV in a host could negatively affect the prognosis of 
malaria infection. Olatunji et al18 also reported that 
HBV and malaria co-infection significantly affect the 
hematological and liver function indices of malaria 
patients in Ilorin, Nigeria. 
 
CONCLUSIONS 
 High prevalence of malaria observed among the 
500 symptomatic patients attending health centers in 
the study area suggests that campaigns about the 
prevention and control of malaria infection should be 
intensified. Presence of malaria parasite in all the 
subjects that are infected with hepatitis and HIV/AIDS 
suggests that these patients should always be 
encouraged to employ all preventive measures such as 
habitat control, use of treated nets and regular medical 
checkup and prompt treatment of malaria when 
infected. Low prevalence of HIV/AIDS observed in 
this research shows high awareness of the disease in the 
study area. This implies that people employed several 
preventive measures against the disease. Nevertheless, 
the HIV/AIDS campaign needs to be intensified to 
control the disease.  
 
LIMITATIONS OF THE STUDY 
 The HBV and HIV tests were done using rapid 
serology assay (diagnostic kits) instead of using 
ELISA, PCR or Western Blot Test due to financial 
constraint. This gap is well noted in the study and will 
subsequently be filled in a later study with fund 
support. 
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